Cargando…
Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer
PURPOSE: This study was conducted to investigate whether a proton pump inhibitor (PPI) could enhance chemosensitivity via the inhibition of vacuolar-type H(+) ATPase (V-ATPase) in cervical cancer. MATERIALS AND METHODS: The expression of V-ATPase was evaluated in 351 formalin-fixed, paraffin-embedde...
Autores principales: | Song, Taejong, Jeon, Hye-Kyung, Hong, Ji Eun, Choi, Jung-Joo, Kim, Tae-Joong, Choi, Chel Hun, Bae, Duk-Soo, Kim, Byoung-Gie, Lee, Jeong-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512380/ https://www.ncbi.nlm.nih.gov/pubmed/27669706 http://dx.doi.org/10.4143/crt.2016.034 |
Ejemplares similares
-
Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma
por: Lee, Yoo-Young, et al.
Publicado: (2015) -
Which is worse: uterine papillary serous carcinomas or carcinosarcomas?
por: Song, Taejong, et al.
Publicado: (2011) -
Histologic distribution of borderline ovarian tumors worldwide: a systematic review
por: Song, Taejong, et al.
Publicado: (2013) -
Clinical significance of HIF-2α immunostaining area in radioresistant cervical cancer
por: Kim, Min Kyu, et al.
Publicado: (2011) -
Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features
por: Kim, Nalee, et al.
Publicado: (2021)